TOPページ
|
英語
日本語
|
CONNECT WITH US:
ホーム
JCNについて
サービス
お問い合わせ
会員企業ログイン
ホーム
プレスリリース一覧
China Medical System Holdings Ltd.
プレスリリース一覧
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 22:00 JST
China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for vitiligo indication of ruxolitinib phosphate cream (the "ruxolitinib cream" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA).
More info..
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023
Aug 16, 2024 14:00 JST
On August 15, 2024, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 interim results announcement, with a steady increase in overall revenue and profit for the period compared to the second half (2H) of 2023. In the first half (1H) of 2024, the Company recorded a turnover of RMB3,611.1 million, representing a decrease of 21.7% compared with 1H 2023, an increase of 6.1% compared with 2H 2023.
More info..
China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China
Aug 05, 2024 23:00 JST
China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 30 July 2024, the New Drug Application (NDA) for an additional indication of Methotrexate Injection (the "Product") has been approved by the National Medical Products Administration of China (NMPA).
More info..
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 21:00 JST
In July 2024, China Medical System Holdings Limited ("CMS" or the "Group") has once again been recognized for its outstanding performance and continuous progress in sustainable development.
More info..
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
Jun 25, 2024 21:46 JST
On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China.
More info..
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
Jun 18, 2024 19:53 JST
More info..
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
Apr 23, 2024 23:06 JST
More info..
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Apr 01, 2024 21:30 JST
More info..
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
Mar 28, 2024 11:29 JST
More info..
China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro(R)
Feb 04, 2024 10:00 JST
More info..
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
Jan 02, 2024 15:00 JST
More info..
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
Dec 13, 2023 18:36 JST
More info..
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
Aug 24, 2023 21:00 JST
More info..
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
Jul 31, 2023 21:00 JST
Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices.
More info..
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China
Jun 12, 2023 21:00 JST
More info..
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
May 30, 2023 23:00 JST
On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
More info..
CMS Releases Its 2022 Interim Report, Achieves Sustained Growth with Its Platform Strategy
Aug 26, 2022 19:00 JST
More info..
1
新着プレスリリース
Business of IP Asia Forum and Entrepreneur Day Unlock IP and Innovation Potential
2024年12月08日 18時21分
三菱重工、フランスとの高速炉開発に関する実施取決めを締結
2024年12月06日 15時37分
富士通、企業のビジネス変革を支援する「SAP Signavio(R)」の活用により、三菱電機エンジニアリング様の業務プロセス改善を提案
2024年12月06日 10時30分
Honda、「N」シリーズの累計販売台数が400万台を突破
2024年12月05日 15時30分
日医工と富士通、AIの活用により医薬品製造DXへの取り組みを推進
2024年12月05日 10時15分
三菱商事、米国DAC事業会社Heirloom Carbon Technologies, Inc社への出資参画について
2024年12月05日 10時00分
富士通、UNHCRフィリッポ・グランディ国連難民高等弁務官と難民支援に関する意見交換を実施
2024年12月04日 10時00分
Acme, Founder of ACET, Calling on Thailand's Embrace of Digital Assets
2024年12月03日 22時00分
三菱重工サーマルシステムズが「令和6年度気候変動アクション環境大臣表彰」を受賞
2024年12月03日 11時50分
富士通の新規事業創出プログラム「Fujitsu Innovation Circuit」から初の出向起業スタートアップが誕生
2024年12月03日 10時30分
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia
2024年12月02日 22時30分
MeAI Sees Strong Support from Top Launchpad CEOs Following Sold-Out IDO
2024年12月02日 22時00分
三菱重工、マカオLRT「石排湾」および「横琴」の両延伸線が営業運転を開始
2024年12月02日 16時30分
富士通、AWSとのグローバルな戦略的協業契約を拡大し、お客様のデジタルトランスフォーメーションを加速
2024年12月02日 13時30分
最新のAIによる⽇本株の銘柄スクリーニングアプリ『AI銘柄スクリーナー』の無料β版をリリース
2024年12月02日 12時15分
三菱重工、台湾高速鉄道の車両基地向けに関連設備の新設・改修工事を受注
2024年11月29日 18時00分
三菱重工、国内製紙工場のソーダ回収ボイラー向けCO2回収実証試験を共同で実施
2024年11月29日 14時00分
HEROWORKS Intensifies Collaboration with a Global Hotel IT Company
2024年11月29日 11時06分
ヒーローワークス、グローバルホテルIT企業との協業を本格化
2024年11月29日 11時00分
Academic Labs (AAX) Selected as the Official Educational Sponsor for the 2024 World Chess Championship in Singapore
2024年11月28日 23時00分
もっと見る >>